Rocket Lab's Cadence Problem: When Reliability Stops Being a Headline

Rocket Lab's perfect launch record and $2.36B backlog clash with investor fears over Iridium acquisition and high valuation, as shares slide 13% below 50-day average.

Rocket Lab has quietly crossed a threshold that most launch providers only dream about. The 93rd Electron mission lifted off from Launch Complex 1 early Friday morning New Zealand time, carrying a QPS-SAR satellite for Japanese operator iQPS into a 575-kilometer orbit. It was the 14th Electron flight of the year, the ninth for iQPS, and another entry in a perfect success record.

Nine more iQPS missions are already booked through 2030, with the contract recently extended by three additional flights. The launch vehicle, bearing the name "The Lightning God Defends," did exactly what it was designed to do. And that, in a nutshell, is the problem.

The Curious Case of a Stock That Won't Cooperate

Investors have spent the past week voting with their feet. The shares closed Thursday at €62.80, down 3.2 percent on the day and 9.4 percent lower over the week. Friday brought a modest recovery to €63.60, a 1.3 percent gain that does little to repair the damage. The stock now sits roughly 13 percent below its 50-day moving average and more than 53 percent off the 52-week high of €133.80 reached in May.

Yet zoom out, and the picture flips dramatically: the shares remain 75 to 78 percent higher over twelve months, depending on the day you measure. With 30-day volatility running at 78 to 79 percent, this is a stock where whiplash is the baseline, not the exception.

What's driving the disconnect? The market's attention has drifted from launch cadence to the balance sheet. Rocket Lab's planned $8 billion acquisition of Iridium — financed in part by a $3.6 billion bridge loan — has become the focal point for both bulls and bears. The recent sell-off also coincided with the release of 319 million SpaceX shares, adding noise to the broader space sector.

The Iridium Calculus

The deal math is straightforward on paper. Iridium brings roughly $870 million in revenue and $114 million in net income, against Rocket Lab's own 2025 figures of approximately $600 million in revenue and a net loss. CEO Peter Beck has been careful to frame the acquisition not as a head-on challenge to Starlink, but as a way to leverage Iridium's L-band spectrum for services that don't yet exist. That's a strategic aspiration, not a proven business model.

For optimists, the combination would create a vertically integrated space company: its own launch vehicle, its own satellite constellations, and 2.55 million Iridium subscribers. A stack that moves beyond rocket-as-a-service into something more durable. The operational fundamentals support the thesis — a backlog that reached $2.36 billion, up 137 percent year over year, and quarterly revenue of $234.1 million that beat expectations. Government contracts add ballast: $981 million from the US Space Force's NITE-STAR program and another $266 million for HASTE launches in Alaska.

The Skeptics' Scorecard

The bear case is equally well-armed. Some market observers peg Rocket Lab's valuation at 91 times revenue — a multiple that even space-sector veterans call rich. The New Glenn explosion at Blue Origin and speculation around SpaceX's valuation triggered a sector-wide correction earlier this year, and Rocket Lab's premium makes it vulnerable to similar shocks.

Then there's the Neutron rocket, the larger vehicle that's supposed to open up bigger payloads and new revenue streams. Its first launch has slipped to the fourth quarter of 2026, a timeline risk that could compress the growth narrative if it slips further. And the Iridium deal remains stuck in financing and regulatory limbo, with the bridge loan needing refinancing and every delay adding pressure to an already aggressive leverage profile.

Reading the Insider Signals

One data point has caught the attention of market watchers: over the past six months, insiders have registered 106 sales and zero purchases. That pattern doesn't necessarily signal a bearish view — diversification sales after big gains are standard practice — but it does reinforce the sense that those closest to the company are comfortable taking some chips off the table while the operational story and the share price move in different directions.

The Real Question

The industry backdrop is shifting in ways that make Rocket Lab's position both more valuable and more contested. Washington signed a new national space transportation policy on Thursday, targeting 1,000 launches per year by 2030 and a lunar mission by 2028. Goldman Sachs projects the global space economy will reach $1.8 trillion by 2035. Meanwhile, China's LandSpace pulled off the first controlled landing of an orbital booster on solid ground by a Chinese private company on Wednesday — a milestone that underscores how quickly the reuse race is spreading beyond SpaceX. The estimated savings: 20 to 50 million yuan per launch, with costs potentially falling 45 percent after five flights.

For Rocket Lab, the competitive pressure in small launch is mounting from multiple directions simultaneously. The company's answer is to lean into what it does best: reliable, repeatable missions for customers like iQPS and Synspective, whose tenth Strix satellite also flew recently. The headlines may get more mundane, but the demand for dependable access to orbit is growing — propelled by political tailwinds in Washington and technological ambition in Beijing.

The next real test isn't another Electron launch. It's whether Rocket Lab can close the Iridium financing, get Neutron off the ground on schedule, and convince the market that a company which has mastered routine can still deliver extraordinary returns. Until then, the stock will likely keep oscillating between operational strength and valuation pressure — a tension that has become the defining feature of Rocket Lab's public market life.